 | • レポートコード：MRC2-11QY00028 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はCD40リガンドのグローバル市場について調査・分析したレポートです。種類別（ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他）市場規模、用途別（B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別CD40リガンドの競争状況、市場シェア ・世界のCD40リガンド市場：種類別市場規模 2015年-2020年（ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他） ・世界のCD40リガンド市場：種類別市場規模予測 2021年-2026年（ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他） ・世界のCD40リガンド市場：用途別市場規模 2015年-2020年（B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他） ・世界のCD40リガンド市場：用途別市場規模予測 2021年-2026年（B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他） ・北米のCD40リガンド市場分析：米国、カナダ ・ヨーロッパのCD40リガンド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのCD40リガンド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のCD40リガンド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのCD40リガンド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biogen, Inc.、Bristol-Myers Squibb Company、eTheRNA Immunotherapies NV、ImmuNext, Inc.、Juno Therapeutics Inc.、MedImmune, LLC、Targovax AS、XL-protein GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global CD40 Ligand Market
The global CD40 Ligand market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global CD40 Ligand Scope and Market Size
CD40 Ligand market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CD40 Ligand market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the CD40 Ligand market is segmented into
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
Segment by Application, the CD40 Ligand market is segmented into
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
Regional and Country-level Analysis
The CD40 Ligand market is analysed and market size information is provided by regions (countries).
The key regions covered in the CD40 Ligand market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and CD40 Ligand Market Share Analysis
CD40 Ligand market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in CD40 Ligand business, the date to enter into the CD40 Ligand market, CD40 Ligand product introduction, recent developments, etc.
The major vendors covered:
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
1 Study Coverage
1.1 CD40 Ligand Product Introduction
1.2 Market Segments
1.3 Key CD40 Ligand Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global CD40 Ligand Market Size Growth Rate by Type
1.4.2 ISF-35
1.4.3 LOAd-700
1.4.4 MEDI-4920
1.4.5 MegaCD40L
1.4.6 Others
1.5 Market by Application
1.5.1 Global CD40 Ligand Market Size Growth Rate by Application
1.5.2 Hepatitis B
1.5.3 Bladder Cancer
1.5.4 Liver Cancer
1.5.5 Ovarian Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global CD40 Ligand Market Size, Estimates and Forecasts
2.1.1 Global CD40 Ligand Revenue 2015-2026
2.1.2 Global CD40 Ligand Sales 2015-2026
2.2 Global CD40 Ligand, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global CD40 Ligand Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global CD40 Ligand Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global CD40 Ligand Competitor Landscape by Players
3.1 CD40 Ligand Sales by Manufacturers
3.1.1 CD40 Ligand Sales by Manufacturers (2015-2020)
3.1.2 CD40 Ligand Sales Market Share by Manufacturers (2015-2020)
3.2 CD40 Ligand Revenue by Manufacturers
3.2.1 CD40 Ligand Revenue by Manufacturers (2015-2020)
3.2.2 CD40 Ligand Revenue Share by Manufacturers (2015-2020)
3.2.3 Global CD40 Ligand Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by CD40 Ligand Revenue in 2019
3.2.5 Global CD40 Ligand Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 CD40 Ligand Price by Manufacturers
3.4 CD40 Ligand Manufacturing Base Distribution, Product Types
3.4.1 CD40 Ligand Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers CD40 Ligand Product Type
3.4.3 Date of International Manufacturers Enter into CD40 Ligand Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global CD40 Ligand Market Size by Type (2015-2020)
4.1.1 Global CD40 Ligand Sales by Type (2015-2020)
4.1.2 Global CD40 Ligand Revenue by Type (2015-2020)
4.1.3 CD40 Ligand Average Selling Price (ASP) by Type (2015-2026)
4.2 Global CD40 Ligand Market Size Forecast by Type (2021-2026)
4.2.1 Global CD40 Ligand Sales Forecast by Type (2021-2026)
4.2.2 Global CD40 Ligand Revenue Forecast by Type (2021-2026)
4.2.3 CD40 Ligand Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global CD40 Ligand Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global CD40 Ligand Market Size by Application (2015-2020)
5.1.1 Global CD40 Ligand Sales by Application (2015-2020)
5.1.2 Global CD40 Ligand Revenue by Application (2015-2020)
5.1.3 CD40 Ligand Price by Application (2015-2020)
5.2 CD40 Ligand Market Size Forecast by Application (2021-2026)
5.2.1 Global CD40 Ligand Sales Forecast by Application (2021-2026)
5.2.2 Global CD40 Ligand Revenue Forecast by Application (2021-2026)
5.2.3 Global CD40 Ligand Price Forecast by Application (2021-2026)
6 North America
6.1 North America CD40 Ligand by Country
6.1.1 North America CD40 Ligand Sales by Country
6.1.2 North America CD40 Ligand Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America CD40 Ligand Market Facts & Figures by Type
6.3 North America CD40 Ligand Market Facts & Figures by Application
7 Europe
7.1 Europe CD40 Ligand by Country
7.1.1 Europe CD40 Ligand Sales by Country
7.1.2 Europe CD40 Ligand Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe CD40 Ligand Market Facts & Figures by Type
7.3 Europe CD40 Ligand Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific CD40 Ligand by Region
8.1.1 Asia Pacific CD40 Ligand Sales by Region
8.1.2 Asia Pacific CD40 Ligand Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific CD40 Ligand Market Facts & Figures by Type
8.3 Asia Pacific CD40 Ligand Market Facts & Figures by Application
9 Latin America
9.1 Latin America CD40 Ligand by Country
9.1.1 Latin America CD40 Ligand Sales by Country
9.1.2 Latin America CD40 Ligand Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America CD40 Ligand Market Facts & Figures by Type
9.3 Central & South America CD40 Ligand Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa CD40 Ligand by Country
10.1.1 Middle East and Africa CD40 Ligand Sales by Country
10.1.2 Middle East and Africa CD40 Ligand Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa CD40 Ligand Market Facts & Figures by Type
10.3 Middle East and Africa CD40 Ligand Market Facts & Figures by Application
11 Company Profiles
11.1 Biogen, Inc.
11.1.1 Biogen, Inc. Corporation Information
11.1.2 Biogen, Inc. Description and Business Overview
11.1.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen, Inc. CD40 Ligand Products Offered
11.1.5 Biogen, Inc. Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company CD40 Ligand Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 eTheRNA Immunotherapies NV
11.3.1 eTheRNA Immunotherapies NV Corporation Information
11.3.2 eTheRNA Immunotherapies NV Description and Business Overview
11.3.3 eTheRNA Immunotherapies NV Sales, Revenue and Gross Margin (2015-2020)
11.3.4 eTheRNA Immunotherapies NV CD40 Ligand Products Offered
11.3.5 eTheRNA Immunotherapies NV Related Developments
11.4 ImmuNext, Inc.
11.4.1 ImmuNext, Inc. Corporation Information
11.4.2 ImmuNext, Inc. Description and Business Overview
11.4.3 ImmuNext, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ImmuNext, Inc. CD40 Ligand Products Offered
11.4.5 ImmuNext, Inc. Related Developments
11.5 Juno Therapeutics Inc.
11.5.1 Juno Therapeutics Inc. Corporation Information
11.5.2 Juno Therapeutics Inc. Description and Business Overview
11.5.3 Juno Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Juno Therapeutics Inc. CD40 Ligand Products Offered
11.5.5 Juno Therapeutics Inc. Related Developments
11.6 MedImmune, LLC
11.6.1 MedImmune, LLC Corporation Information
11.6.2 MedImmune, LLC Description and Business Overview
11.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MedImmune, LLC CD40 Ligand Products Offered
11.6.5 MedImmune, LLC Related Developments
11.7 Targovax AS
11.7.1 Targovax AS Corporation Information
11.7.2 Targovax AS Description and Business Overview
11.7.3 Targovax AS Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Targovax AS CD40 Ligand Products Offered
11.7.5 Targovax AS Related Developments
11.8 XL-protein GmbH
11.8.1 XL-protein GmbH Corporation Information
11.8.2 XL-protein GmbH Description and Business Overview
11.8.3 XL-protein GmbH Sales, Revenue and Gross Margin (2015-2020)
11.8.4 XL-protein GmbH CD40 Ligand Products Offered
11.8.5 XL-protein GmbH Related Developments
11.1 Biogen, Inc.
11.1.1 Biogen, Inc. Corporation Information
11.1.2 Biogen, Inc. Description and Business Overview
11.1.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen, Inc. CD40 Ligand Products Offered
11.1.5 Biogen, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 CD40 Ligand Market Estimates and Projections by Region
12.1.1 Global CD40 Ligand Sales Forecast by Regions 2021-2026
12.1.2 Global CD40 Ligand Revenue Forecast by Regions 2021-2026
12.2 North America CD40 Ligand Market Size Forecast (2021-2026)
12.2.1 North America: CD40 Ligand Sales Forecast (2021-2026)
12.2.2 North America: CD40 Ligand Revenue Forecast (2021-2026)
12.2.3 North America: CD40 Ligand Market Size Forecast by Country (2021-2026)
12.3 Europe CD40 Ligand Market Size Forecast (2021-2026)
12.3.1 Europe: CD40 Ligand Sales Forecast (2021-2026)
12.3.2 Europe: CD40 Ligand Revenue Forecast (2021-2026)
12.3.3 Europe: CD40 Ligand Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific CD40 Ligand Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: CD40 Ligand Sales Forecast (2021-2026)
12.4.2 Asia Pacific: CD40 Ligand Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: CD40 Ligand Market Size Forecast by Region (2021-2026)
12.5 Latin America CD40 Ligand Market Size Forecast (2021-2026)
12.5.1 Latin America: CD40 Ligand Sales Forecast (2021-2026)
12.5.2 Latin America: CD40 Ligand Revenue Forecast (2021-2026)
12.5.3 Latin America: CD40 Ligand Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa CD40 Ligand Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: CD40 Ligand Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: CD40 Ligand Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: CD40 Ligand Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key CD40 Ligand Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 CD40 Ligand Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. CD40 Ligand Market Segments
Table 2. Ranking of Global Top CD40 Ligand Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global CD40 Ligand Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ISF-35
Table 5. Major Manufacturers of LOAd-700
Table 6. Major Manufacturers of MEDI-4920
Table 7. Major Manufacturers of MegaCD40L
Table 8. Major Manufacturers of Others
Table 9. Global CD40 Ligand Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global CD40 Ligand Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global CD40 Ligand Sales by Regions 2015-2020 (K Pcs)
Table 12. Global CD40 Ligand Sales Market Share by Regions (2015-2020)
Table 13. Global CD40 Ligand Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global CD40 Ligand Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global CD40 Ligand Sales Share by Manufacturers (2015-2020)
Table 16. Global CD40 Ligand Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global CD40 Ligand by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD40 Ligand as of 2019)
Table 18. CD40 Ligand Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. CD40 Ligand Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers CD40 Ligand Price (2015-2020) (USD/Pcs)
Table 21. CD40 Ligand Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers CD40 Ligand Product Type
Table 23. Date of International Manufacturers Enter into CD40 Ligand Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 26. Global CD40 Ligand Sales Share by Type (2015-2020)
Table 27. Global CD40 Ligand Revenue by Type (2015-2020) (US$ Million)
Table 28. Global CD40 Ligand Revenue Share by Type (2015-2020)
Table 29. CD40 Ligand Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 31. Global CD40 Ligand Sales Share by Application (2015-2020)
Table 32. North America CD40 Ligand Sales by Country (2015-2020) (K Pcs)
Table 33. North America CD40 Ligand Sales Market Share by Country (2015-2020)
Table 34. North America CD40 Ligand Revenue by Country (2015-2020) (US$ Million)
Table 35. North America CD40 Ligand Revenue Market Share by Country (2015-2020)
Table 36. North America CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 37. North America CD40 Ligand Sales Market Share by Type (2015-2020)
Table 38. North America CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 39. North America CD40 Ligand Sales Market Share by Application (2015-2020)
Table 40. Europe CD40 Ligand Sales by Country (2015-2020) (K Pcs)
Table 41. Europe CD40 Ligand Sales Market Share by Country (2015-2020)
Table 42. Europe CD40 Ligand Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe CD40 Ligand Revenue Market Share by Country (2015-2020)
Table 44. Europe CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 45. Europe CD40 Ligand Sales Market Share by Type (2015-2020)
Table 46. Europe CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 47. Europe CD40 Ligand Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific CD40 Ligand Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific CD40 Ligand Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific CD40 Ligand Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific CD40 Ligand Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific CD40 Ligand Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific CD40 Ligand Sales Market Share by Application (2015-2020)
Table 56. Latin America CD40 Ligand Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America CD40 Ligand Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa CD40 Ligand Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America CD40 Ligand Revenue Market Share by Country (2015-2020)
Table 60. Latin America CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America CD40 Ligand Sales Market Share by Type (2015-2020)
Table 62. Latin America CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America CD40 Ligand Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa CD40 Ligand Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa CD40 Ligand Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa CD40 Ligand Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa CD40 Ligand Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa CD40 Ligand Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa CD40 Ligand Sales Market Share by Application (2015-2020)
Table 72. Biogen, Inc. Corporation Information
Table 73. Biogen, Inc. Description and Major Businesses
Table 74. Biogen, Inc. CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Biogen, Inc. Product
Table 76. Biogen, Inc. Recent Development
Table 77. Bristol-Myers Squibb Company Corporation Information
Table 78. Bristol-Myers Squibb Company Description and Major Businesses
Table 79. Bristol-Myers Squibb Company CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bristol-Myers Squibb Company Product
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. eTheRNA Immunotherapies NV Corporation Information
Table 83. eTheRNA Immunotherapies NV Description and Major Businesses
Table 84. eTheRNA Immunotherapies NV CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. eTheRNA Immunotherapies NV Product
Table 86. eTheRNA Immunotherapies NV Recent Development
Table 87. ImmuNext, Inc. Corporation Information
Table 88. ImmuNext, Inc. Description and Major Businesses
Table 89. ImmuNext, Inc. CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. ImmuNext, Inc. Product
Table 91. ImmuNext, Inc. Recent Development
Table 92. Juno Therapeutics Inc. Corporation Information
Table 93. Juno Therapeutics Inc. Description and Major Businesses
Table 94. Juno Therapeutics Inc. CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Juno Therapeutics Inc. Product
Table 96. Juno Therapeutics Inc. Recent Development
Table 97. MedImmune, LLC Corporation Information
Table 98. MedImmune, LLC Description and Major Businesses
Table 99. MedImmune, LLC CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. MedImmune, LLC Product
Table 101. MedImmune, LLC Recent Development
Table 102. Targovax AS Corporation Information
Table 103. Targovax AS Description and Major Businesses
Table 104. Targovax AS CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Targovax AS Product
Table 106. Targovax AS Recent Development
Table 107. XL-protein GmbH Corporation Information
Table 108. XL-protein GmbH Description and Major Businesses
Table 109. XL-protein GmbH CD40 Ligand Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. XL-protein GmbH Product
Table 111. XL-protein GmbH Recent Development
Table 112. Global CD40 Ligand Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global CD40 Ligand Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global CD40 Ligand Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global CD40 Ligand Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: CD40 Ligand Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: CD40 Ligand Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: CD40 Ligand Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: CD40 Ligand Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: CD40 Ligand Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: CD40 Ligand Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: CD40 Ligand Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: CD40 Ligand Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: CD40 Ligand Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: CD40 Ligand Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key CD40 Ligand Players
Table 130. CD40 Ligand Customers List
Table 131. CD40 Ligand Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. CD40 Ligand Product Picture
Figure 2. Global CD40 Ligand Sales Market Share by Type in 2020 & 2026
Figure 3. ISF-35 Product Picture
Figure 4. LOAd-700 Product Picture
Figure 5. MEDI-4920 Product Picture
Figure 6. MegaCD40L Product Picture
Figure 7. Others Product Picture
Figure 8. Global CD40 Ligand Sales Market Share by Application in 2020 & 2026
Figure 9. Hepatitis B
Figure 10. Bladder Cancer
Figure 11. Liver Cancer
Figure 12. Ovarian Cancer
Figure 13. Others
Figure 14. CD40 Ligand Report Years Considered
Figure 15. Global CD40 Ligand Market Size 2015-2026 (US$ Million)
Figure 16. Global CD40 Ligand Sales 2015-2026 (K Pcs)
Figure 17. Global CD40 Ligand Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global CD40 Ligand Sales Market Share by Region (2015-2020)
Figure 19. Global CD40 Ligand Sales Market Share by Region in 2019
Figure 20. Global CD40 Ligand Revenue Market Share by Region (2015-2020)
Figure 21. Global CD40 Ligand Revenue Market Share by Region in 2019
Figure 22. Global CD40 Ligand Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by CD40 Ligand Revenue in 2019
Figure 24. CD40 Ligand Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global CD40 Ligand Sales Market Share by Type (2015-2020)
Figure 26. Global CD40 Ligand Sales Market Share by Type in 2019
Figure 27. Global CD40 Ligand Revenue Market Share by Type (2015-2020)
Figure 28. Global CD40 Ligand Revenue Market Share by Type in 2019
Figure 29. Global CD40 Ligand Market Share by Price Range (2015-2020)
Figure 30. Global CD40 Ligand Sales Market Share by Application (2015-2020)
Figure 31. Global CD40 Ligand Sales Market Share by Application in 2019
Figure 32. Global CD40 Ligand Revenue Market Share by Application (2015-2020)
Figure 33. Global CD40 Ligand Revenue Market Share by Application in 2019
Figure 34. North America CD40 Ligand Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America CD40 Ligand Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America CD40 Ligand Sales Market Share by Country in 2019
Figure 37. North America CD40 Ligand Revenue Market Share by Country in 2019
Figure 38. U.S. CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America CD40 Ligand Market Share by Type in 2019
Figure 43. North America CD40 Ligand Market Share by Application in 2019
Figure 44. Europe CD40 Ligand Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe CD40 Ligand Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe CD40 Ligand Sales Market Share by Country in 2019
Figure 47. Europe CD40 Ligand Revenue Market Share by Country in 2019
Figure 48. Germany CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe CD40 Ligand Market Share by Type in 2019
Figure 59. Europe CD40 Ligand Market Share by Application in 2019
Figure 60. Asia Pacific CD40 Ligand Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific CD40 Ligand Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific CD40 Ligand Sales Market Share by Region in 2019
Figure 63. Asia Pacific CD40 Ligand Revenue Market Share by Region in 2019
Figure 64. China CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific CD40 Ligand Market Share by Type in 2019
Figure 87. Asia Pacific CD40 Ligand Market Share by Application in 2019
Figure 88. Latin America CD40 Ligand Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America CD40 Ligand Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America CD40 Ligand Sales Market Share by Country in 2019
Figure 91. Latin America CD40 Ligand Revenue Market Share by Country in 2019
Figure 92. Mexico CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America CD40 Ligand Market Share by Type in 2019
Figure 99. Latin America CD40 Ligand Market Share by Application in 2019
Figure 100. Middle East and Africa CD40 Ligand Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa CD40 Ligand Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa CD40 Ligand Sales Market Share by Country in 2019
Figure 103. Middle East and Africa CD40 Ligand Revenue Market Share by Country in 2019
Figure 104. Turkey CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E CD40 Ligand Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E CD40 Ligand Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa CD40 Ligand Market Share by Type in 2019
Figure 111. Middle East and Africa CD40 Ligand Market Share by Application in 2019
Figure 112. North America CD40 Ligand Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America CD40 Ligand Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe CD40 Ligand Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe CD40 Ligand Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific CD40 Ligand Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific CD40 Ligand Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America CD40 Ligand Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America CD40 Ligand Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa CD40 Ligand Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa CD40 Ligand Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣がんの世界市場（～2026年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- 膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 卵巣がん治療薬の世界市場（～2026年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…
- ナルコレプシー治療の世界市場（～2026年） Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimu…